journal article·2024-12Open access

Immune Checkpoints in B Cells: Unlocking New Potentials in Cancer Treatment

Xiaoye Shi, Xiangshu Cheng, Aimin Jiang, Wenjie Shi, Lingxuan Zhu, Weiming Mou, Antonino Glaviano, Zaoqu Liu, Quan Cheng, Anqi Lin, Linhui Wang, Peng Luo

Advanced Science· Volume 11· Issue 47

Abstract

Abstract B cells are crucial component of humoral immunity, and their role in the tumor immune microenvironment (TME) has garnered significant attention in recent years. These cells hold great potential and application prospects in the field of tumor immunotherapy. Research has demonstrated that the TME can remodel various B cell functions, including proliferation, differentiation, antigen presentation, and antibody production, thereby invalidating the anti‐tumor effects of B cells. Concurrently, numerous immune checkpoints (ICs) on the surface of B cells are upregulated. Aberrant B‐cell IC signals not only impair the function of B cells themselves, but also modulate the tumor‐killing effects of other immune cells, ultimately fostering an immunosuppressive TME and facilitating tumor immune escape. Blocking ICs on B cells is beneficial for reversing the immunosuppressive TME and restoring anti‐tumor immune responses. In this paper, the intricate connection between B‐cell ICs and the TME is delved into, emphasizing the critical role of targeting B‐cell ICs in anti‐tumor immunity, which may provide valuable insights for the future development of tumor immunotherapy based on B cells.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Immune Cell Function and Interaction · Cancer Immunotherapy and Biomarkers · CAR-T cell therapy research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Oncology Zhujiang Hospital Southern Medical University Guangzhou Guangdong 510282 China

The Second School of Clinical Medicine Southern Medical University Guangzhou Guangdong 510515 China

College of Bioinformatics Science and Technology Harbin Medical University 157 Baojian Road. Nangang District, Harbin Heilongiiang 150076 China

Department of Urology Changhai Hospital Naval Medical University (Second Military Medical University) Shanghai 200433 China

Molecular and Experimental Surgery University Clinic for General‐ Visceral‐ Vascular‐ and Trans‐Plantation Surgery Medical Faculty University Hospital Magdeburg Otto‐von Guericke University 39120 Magdeburg Germany

Department of Urology Shanghai General Hospital Shanghai Jiao Tong University School of Medicine Shanghai 200080 China

Department of Biological Chemical and Pharmaceutical Sciences and Technologies University of Palermo Palermo 90123 Italy

Institute of Basic Medical Sciences Chinese Academy of Medical Sciences and Peking Union Medical College Beijing 100730 China

Department of Neurosurgery Xiangya Hospital Central South University Changsha 410008 China

National Clinical Research Center for Geriatric Disorders Xiangya Hospital Central South University Changsha 410008 China

Cancer Centre and Institute of Translational Medicine Faculty of Health Sciences University of Macau Macau SAR 999078 China

Funding

National Natural Science Foundation of China

References (100+)

Show source-provided references
1. 10.1016/j.smim.2022.10170710.1016/j.smim.2022.101707 ↗
2. 10.1158/2326-6066.CIR-19-034910.1158/2326-6066.CIR-19-0349 ↗
3. 10.1016/j.yexcr.2019.11165210.1016/j.yexcr.2019.111652 ↗
4. 10.1002/cti2.127010.1002/cti2.1270 ↗
5. 10.1038/s41568-022-00466-110.1038/s41568-022-00466-1 ↗
6. 10.1158/0008-5472.CAN-06-388910.1158/0008-5472.CAN-06-3889 ↗
7. 10.4049/jimmunol.130023110.4049/jimmunol.1300231 ↗
8. 10.1593/neo.1102410.1593/neo.11024 ↗
9. 10.1016/j.ccell.2021.09.00710.1016/j.ccell.2021.09.007 ↗
10. 10.1186/s40425-019-0726-610.1186/s40425-019-0726-6 ↗
11. 10.1016/j.immuni.2022.02.00910.1016/j.immuni.2022.02.009 ↗
12. 10.1038/s41571-022-00619-z10.1038/s41571-022-00619-z ↗
13. 10.1016/j.immuni.2022.02.00110.1016/j.immuni.2022.02.001 ↗
14. 10.1136/gutjnl-2022-32869710.1136/gutjnl-2022-328697 ↗
15. 10.1136/jitc-2020-00227310.1136/jitc-2020-002273 ↗
16. 10.1038/s41467-020-17670-y10.1038/s41467-020-17670-y ↗
17. 10.1146/annurev-pathol-042020-04274110.1146/annurev-pathol-042020-042741 ↗
18. 10.1038/s41422-020-0343-410.1038/s41422-020-0343-4 ↗
19. 10.1016/1074-7613(95)90125-610.1016/1074-7613(95)90125-6 ↗
20. 10.3389/fimmu.2020.0016710.3389/fimmu.2020.00167 ↗
21. 10.3389/fimmu.2023.119963110.3389/fimmu.2023.1199631 ↗
22. 10.1038/s41590-018-0132-010.1038/s41590-018-0132-0 ↗
23. 10.1038/s43018-023-00598-910.1038/s43018-023-00598-9 ↗
24. 10.3390/biom1308120910.3390/biom13081209 ↗
25. 10.3389/fphar.2021.73179810.3389/fphar.2021.731798 ↗
26. 10.1038/s41586-023-06231-010.1038/s41586-023-06231-0 ↗
27. 10.1158/0008-5472.CAN-16-034210.1158/0008-5472.CAN-16-0342 ↗
28. 10.1016/j.intimp.2022.10873510.1016/j.intimp.2022.108735 ↗
29. 10.1158/0008-5472.CAN-10-431610.1158/0008-5472.CAN-10-4316 ↗
30. 10.1158/1538‐7445.SABCS21‐P1‐04‐1010.1158/1538‐7445.SABCS21‐P1‐04‐10 ↗
31. 10.1038/s41392-023-01643-w10.1038/s41392-023-01643-w ↗
32. 10.1038/s41467-019-12160-210.1038/s41467-019-12160-2 ↗
33. 10.4049/jimmunol.120192010.4049/jimmunol.1201920 ↗
34. 10.3389/fimmu.2016.0017310.3389/fimmu.2016.00173 ↗
35. 10.2119/molmed.2015.0008310.2119/molmed.2015.00083 ↗
36. 10.4049/jimmunol.130043810.4049/jimmunol.1300438 ↗
37. 10.1089/ars.2007.162810.1089/ars.2007.1628 ↗
38. 10.3389/fimmu.2022.96757610.3389/fimmu.2022.967576 ↗
39. 10.1177/1533033821103630410.1177/15330338211036304 ↗
40. 10.1016/j.canlet.2023.21607610.1016/j.canlet.2023.216076 ↗
41. 10.4049/jimmunol.170106910.4049/jimmunol.1701069 ↗
42. 10.1016/j.imlet.2017.07.00310.1016/j.imlet.2017.07.003 ↗
43. 10.4049/jimmunol.150095710.4049/jimmunol.1500957 ↗
44. 10.1016/S1074-7613(00)00044-310.1016/S1074-7613(00)00044-3 ↗
45. 10.1016/j.canlet.2022.21592510.1016/j.canlet.2022.215925 ↗
46. 10.1158/0008-5472.CAN-12-418410.1158/0008-5472.CAN-12-4184 ↗
47. 10.1158/0008-5472.CAN-19-105810.1158/0008-5472.CAN-19-1058 ↗
48. 10.1038/s41467-022-33117-y10.1038/s41467-022-33117-y ↗
49. 10.1186/s40425-018-0451-610.1186/s40425-018-0451-6 ↗
50. 10.1158/2159-8290.CD-15-140810.1158/2159-8290.CD-15-1408 ↗
51. 10.1080/2162402X.2017.141352010.1080/2162402X.2017.1413520 ↗
52. 10.1038/s41419-021-03745-110.1038/s41419-021-03745-1 ↗
53. 10.1016/j.immuni.2016.04.00310.1016/j.immuni.2016.04.003 ↗
54. 10.1002/hep.3244210.1002/hep.32442 ↗
55. 10.1007/s13277-015-4687-110.1007/s13277-015-4687-1 ↗
56. 10.1080/2162402X.2016.118048510.1080/2162402X.2016.1180485 ↗
57. He H. · Am. J. Cancer Res. · 2017 · 7 · 1151
58. 10.1038/s41586-021-04082-110.1038/s41586-021-04082-1 ↗
59. 10.1080/2162402X.2021.187358510.1080/2162402X.2021.1873585 ↗
60. 10.1158/0008-5472.CAN-14-307710.1158/0008-5472.CAN-14-3077 ↗
61. 10.1182/blood-2008-10-18542110.1182/blood-2008-10-185421 ↗
62. 10.1016/j.immuni.2008.11.00710.1016/j.immuni.2008.11.007 ↗
63. 10.1038/s41577-019-0257-x10.1038/s41577-019-0257-x ↗
64. 10.1007/s00262-020-02535-610.1007/s00262-020-02535-6 ↗
65. 10.1016/j.xcrm.2022.10074410.1016/j.xcrm.2022.100744 ↗
66. 10.1155/2010/65740610.1155/2010/657406 ↗
67. 10.1038/7470410.1038/74704 ↗
68. 10.1038/s41568-023-00637-810.1038/s41568-023-00637-8 ↗
69. 10.1016/j.ccr.2009.12.01910.1016/j.ccr.2009.12.019 ↗
70. 10.4049/jimmunol.210033610.4049/jimmunol.2100336 ↗
71. 10.14715/cmb/2022.68.11.810.14715/cmb/2022.68.11.8 ↗
72. 10.1016/j.celrep.2018.06.04610.1016/j.celrep.2018.06.046 ↗
73. 10.3389/fimmu.2022.95493610.3389/fimmu.2022.954936 ↗
74. 10.7150/jca.5733410.7150/jca.57334 ↗
75. 10.1016/j.molimm.2019.02.00910.1016/j.molimm.2019.02.009 ↗
76. 10.1093/intimm/dxs09810.1093/intimm/dxs098 ↗
77. 10.1073/pnas.23148659810.1073/pnas.231486598 ↗
78. 10.1038/s41586-019-1922-810.1038/s41586-019-1922-8 ↗
79. 10.1093/intimm/dxw00710.1093/intimm/dxw007 ↗
80. 10.1111/1440-1681.1331710.1111/1440-1681.13317 ↗
81. 10.1007/978-981-15-3266-5_210.1007/978-981-15-3266-5_2 ↗
82. 10.1136/jitc-2020-00095710.1136/jitc-2020-000957 ↗
83. 10.1080/2162402X.2022.210442610.1080/2162402X.2022.2104426 ↗
84. 10.1007/s12026-013-8472-110.1007/s12026-013-8472-1 ↗
85. 10.1158/0008-5472.CAN-05-376610.1158/0008-5472.CAN-05-3766 ↗
86. 10.1111/bjh.1796810.1111/bjh.17968 ↗
87. 10.2174/092986732866620122912315110.2174/0929867328666201229123151 ↗
88. 10.4049/jimmunol.171.11.570710.4049/jimmunol.171.11.5707 ↗
89. 10.1126/sciimmunol.add182310.1126/sciimmunol.add1823 ↗
90. 10.4049/jimmunol.210034110.4049/jimmunol.2100341 ↗
91. 10.3390/cancers1402029410.3390/cancers14020294 ↗
92. Chikuma S. · Curr. Top. Microbiol. Immunol. · 2017 · 410 · 99
93. 10.1016/j.smim.2021.10148010.1016/j.smim.2021.101480 ↗
94. 10.1158/1078-0432.CCR-23-025810.1158/1078-0432.CCR-23-0258 ↗
95. 10.1186/s13045-020-01027-510.1186/s13045-020-01027-5 ↗
96. 10.1073/pnas.19246109910.1073/pnas.192461099 ↗
97. 10.1002/hep.3146610.1002/hep.31466 ↗
98. 10.1084/jem.2011274110.1084/jem.20112741 ↗
99. 10.1083/jcb.20190508510.1083/jcb.201905085 ↗
100. 10.1002/cam4.297610.1002/cam4.2976 ↗